Smoltek has received an order to perform proof-of-concept study for medtech devices
This press release is an English version of the previously published Swedish version, which has interpretive precedence. Smoltek Nanotech Holding AB (“Smoltek”) announces that the company has received an order, worth 40,000 euros, to perform a proof-of-concept study using the company’s unique carbon nanofiber technology in solving a difficult materials engineering problem for a global medtech company.The purpose of the proof-of-concept study is to confirm that Smoltek’s electrically conductive, vertically aligned carbon nanofibers can function as an interconnect between an integrated